Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|March 31, 2018
Re-evaluation of Adrenocorticotropic Hormone and Melanocyte Stimulating Hormone Activation of GPR139 in VitroDiane Nepomuceno, Chester Kuei, Curt Dvorak, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Fluoro analogs of bioactive oxy-sterols: Synthesis of an EBI2 agonist with enhanced metabolic stabilityXiaohu Deng, Siquan Sun, Jiejun Wu, et al.
Molecular Pharmacology|October 7, 2004
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7Changlu Liu, Jingcai Chen, Chester Kuei, et al.
Annals of the New York Academy of Sciences|June 16, 2005
Recent progress in relaxin-3-related researchChanglu Liu, Pascal Bonaventure, Steven W Sutton, et al.
The Journal of Biological Chemistry|October 3, 2003
Identification of relaxin-3/INSL7 as a ligand for GPCR142Changlu Liu, Jingcai Chen, Steven Sutton, et al.
Frontiers in Neuroscience|April 12, 2019
GPR139 and Dopamine D2 Receptor Co-express in the Same Cells of the Brain and May Functionally InteractLien Wang, Grace Lee, Chester Kuei, et al.
Molecular Pharmacology|August 25, 2011
Study of GPR81, the lactate receptor, from distant species identifies residues and motifs critical for GPR81 functionsChester Kuei, Jingxue Yu, Jessica Zhu, et al.
Neuroendocrinology|January 29, 2005
Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processingSteven W Sutton, Pascal Bonaventure, Chester Kuei, et al.
Neuroendocrinology|May 9, 2006
G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135Steven W Sutton, Pascal Bonaventure, Chester Kuei, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic EffectsCurt A Dvorak, Changlu Liu, Jonathan Shelton, et al.
Pageof 4